SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001193125-22-031005
Filing Date
2022-02-08
Accepted
2022-02-08 16:02:45
Documents
8
Effectiveness Date
2022-02-08

Document Format Files

Seq Description Document Type Size
1 POSASR d270841dposasr.htm POSASR 457385
2 EX-5.1 d270841dex51.htm EX-5.1 15840
3 EX-23.1 d270841dex231.htm EX-23.1 1611
4 EX-FILING FEES d270841dexfilingfees.htm EX-FILING FEES 108931
5 GRAPHIC g270841g0205094314263.jpg GRAPHIC 4696
6 GRAPHIC g270841g0205094315031.jpg GRAPHIC 4932
7 GRAPHIC g270841g0205094315462.jpg GRAPHIC 4594
8 GRAPHIC g270841g0205100238721.jpg GRAPHIC 2747
  Complete submission text file 0001193125-22-031005.txt   608872
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-236389 | Film No.: 22601553
SIC: 2834 Pharmaceutical Preparations